Efficacy analysis of three‑year subcutaneous SQ‑standardized specific immunotherapy in house dust mite‑allergic children with asthma

Hui,Yu; Li,Ling; Qian,Jun; Guo,Yun; Zhang,Xilian; Zhang,Xiaojuan

doi:10.3892/etm.2014.1469

2014-March Volume 7 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

2014-March Volume 7 Issue 3

Full Size Image

Article

Efficacy analysis of three‑year subcutaneous SQ‑standardized specific immunotherapy in house dust mite‑allergic children with asthma

Authors:
- Yu Hui
- Ling Li
- Jun Qian
- Yun Guo
- Xilian Zhang
- Xiaojuan Zhang
View Affiliations / Copyright

Affiliations: Department of Respiratory Medicine, Wuxi Children's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, P.R. China
Pages: 630-634
|
Published online on: January 2, 2014

https://doi.org/10.3892/etm.2014.1469
Expand metrics +

Abstract

The present study aimed to evaluate the efficacy of three-year subcutaneous SQ‑standardized specific immunotherapy (SCIT) in house dust mite (HDM)-allergic children with asthma. Ninety children with allergic asthma to HDMs, with or without allergic rhinitis, were randomly divided into two groups, the treatment group and the control group. The treatment group received SCIT combined with standardized glucocorticoid management and the control group received standardized glucocorticoid management alone for a period of three years. The mean daily dose of inhaled corticosteroids (ICSs), a four‑week diary recording the symptom scores of asthma, peak expiratory flow (PEF) measurements, skin prick test results and serum immunoglobulin E (IgE) levels were assessed prior to treatment and following one, two and three years of treatment. The median dose of ICS was reduced in the treatment group after two and three years of treatment compared with that of the control group. After three years of treatment, the discontinuation percentage of ICS in the treatment group was higher than that in the control group. The treatment group demonstrated significantly reduced daytime and night‑time asthmatic symptom scores, increased PEF values and reduced serum IgE levels after two and three years of treatment compared with those in the control group (P﹤0.05). In conclusion, three‑year SCIT treatment combined with ICS is an effective immunotherapy for children with allergic asthma and resulted in a reduction of the required ICS dose.

View Figures

View References

1	Carrard A and Pichler C: House dust mite allergy. Ther Umsch. 69:249–252. 2012.(In German).
2	Barnes PJ: New drugs for asthma. Semin Respir Crit Care Med. 33:685–694. 2012. View Article : Google Scholar
3	Wang CM and Chuang JJ: Effect of mite allergen immunotherapy on the altered phenotype of dendritic cells in allergic asthmatic children. Ann Allergy Asthma Immunol. 110:107–112. 2013. View Article : Google Scholar : PubMed/NCBI
4	Maazi H, Shirinbak S, Willart M, et al: Contribution of regulatory T cells to alleviation of experimental allergic asthma after specific immunotherapy. Clin Exp Allergy. 42:1519–1528. 2012. View Article : Google Scholar : PubMed/NCBI
5	Eifan AO, Akkoc T, Yildiz A, Keles S, Ozdemir C, Bahceciler NN and Barlan IB: Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial. Clin Exp Allergy. 40:922–932. 2010. View Article : Google Scholar
6	Blumberga G, Groes L and Dahl R: SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma. Allergy. 66:178–185. 2011. View Article : Google Scholar : PubMed/NCBI
7	The Breathing Group of Pediatric Academy affiliated to Chinese Medical Association and the Editorial Board of Chinese Journal of Pediatrics affiliated to Chinese Medical Association. The routine for prevention and treatment of bronchial asthma in children (for trial). Zhonghua Er Ke Za Zhi. 42:100–106. 2004.(In Chinese).
8	Yang BZ, Chen HB, Hou JM, et al: Clinical analysis on 520 children with bronchial asthma of allergens by skin prick test. Journal of North Sichuan Medical College. 26:331–333. 2011.(In Chinese).
9	Akdis CA and Akdis M: Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol. 127:18–27. 2011. View Article : Google Scholar : PubMed/NCBI
10	Han J, Huang Y and Wang MK: Influence of specific immunotherapy on Dermatophagoides pteronyssinus-specific IgG4 and pulmonary function in children suffering from allergic asthma. Journal of Third Military Medical University. 33:618–620. 2011.(In Chinese).
11	Cox L, Calderón M and Pfaar O: Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations. Immunotherapy. 4:601–616. 2012. View Article : Google Scholar : PubMed/NCBI
12	Gonzales M, Fratianni C, Mamillapali C and Khardori R: Immunotherapy in miscellaneous medical disorders Graves ophthalmopathy, asthma, and regional painful syndrome. Med Clin North Am. 96:635–654. 2012. View Article : Google Scholar : PubMed/NCBI
13	Trebuchon F, David M and Demoly P: Medical management and sublingual immunotherapy practices in patients with house dust mite-induced respiratory allergy: a retrospective, observational study. Int J Immunopathol Pharmacol. 25:193–206. 2012.
14	Hedlin G and van Hage M: The role of immunotherapy in the management of childhood asthma. Ther Adv Respir Dis. 6:137–146. 2012. View Article : Google Scholar : PubMed/NCBI
15	La Rosa M, Lionetti E, Leonardi S, et al: Specific immunotherapy in children: the evidence. Int J Immunopathol Pharmacol. 24:69–78. 2011.PubMed/NCBI
16	Stelmach I, Sobocińska A, Majak P, Smejda K, Jerzyńska J and Stelmach W: Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy. Ann Allergy Asthma Immunol. 109:274–278. 2012.PubMed/NCBI
17	Eifan AO, Shamji MH and Durham SR: Long-term clinical and immunological effects of allergen immunotherapy. Curr Opin Allergy Clin Immunol. 11:586–593. 2011. View Article : Google Scholar : PubMed/NCBI
18	Klimek L, Mewes T, Wolf H, Hansen I, Schnitker J and Mann WJ: The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity. Otolaryngol Head Neck Surg. 133:538–543. 2005. View Article : Google Scholar
19	Creticos PS: The consideration of immunotherapy in the treatment of allergic asthma. J Allergy Clin Immunol. 105:S559–S574. 2000. View Article : Google Scholar : PubMed/NCBI
20	Frew AJ: 25. Immunotherapy of allergic disease. J Allergy Clin Immunol. 111(Suppl 2): S712–S719. 2003. View Article : Google Scholar : PubMed/NCBI
21	Mellerup MT, Hahn GW, Poulsen LK and Malling H: Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clin Exp Allergy. 30:1423–1429. 2000. View Article : Google Scholar

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Efficacy analysis of three‑year subcutaneous SQ‑standardized specific immunotherapy in house dust mite‑allergic children with asthma

This article is mentioned in:

Abstract

Figure 1

Related Articles